Drugs.com: Lowering blood pressure after clot removal may not be safe
Drugs.com highlighted University of Cincinnati stroke research recently published in JAMA.
Led by UC's Eva Mistry, MBBS, the BEST-II trial found using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal.
"Although the study did not find significant evidence of an unequivocal harm of lower blood pressure targets in this population in terms of worsening size of stroke or increasing disability, the trends indicated that there may only be marginal benefit of lowering postendovascular treatment blood pressure on patients' long-term disability," said Mistry, assistant professor in the Department of Neurology and Rehabilitation medicine in UC’s College of Medicine and a UC Health physician at the UC Gardner Neuroscience Institute.
Read the Drugs.com article, originally published by HealthDay.
Featured image at top of a health professional measuring a patient's blood pressure. Photo/Siarhei Khaletski/iStock Photos.
Related Stories
UC studies: Silent mutations, tumor microenvironment may be therapeutic targets
April 17, 2026
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2026 April 17 to 22 in San Diego.
New UC Blue Ash business officer is a familiar face on campus
April 17, 2026
Lacey McCarthy will bring her skills, expertise and more than 20 years of experience in budget and financing to her new role as business officer for the University of Cincinnati Blue Ash College.
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.